Trans isomers of a-linolenic acid, which are formed by deodorization of refined vegetable oils, can be found in significant amounts in edible oils. Effects of trans a-linolenic acid on plasma lipoproteins are unknown. We therefore investigated the effects of trans a-linolenic acid on plasma lipids and lipoproteins in healthy European men. Eighty-eight healthy men from three European countries (France, Scotland, UK and the Netherlands) first consumed for 6 weeks a diet with experimental oils`free' of trans fatty acids (run-in period). For the next 6 weeks, they were randomly allocated to a diet with experimental oils`high' or`low' in trans a-linolenic acid. Daily total trans a-linolenic acid intake in the high trans group was 1410 (range 583± 2642) mg. Experimental oils were provided as such, or incorporated into margarines, cheeses, muffins and biscuits. The high trans a-linolenic acid diet significantly increased the plasma LDL-:HDL-cholesterol ratio by 8´1 % (95 % CI 1´4, 15´3; P 0´02Y and the total cholesterol:HDL-cholesterol ratio by 5´1 % (95 % CI 0´4, 9´9; P 0´03 compared with the low-trans diet. This was largely explained by an increase in LDL-cholesterol on the high-trans diet, while no change was observed in the low-trans group (mean treatment effect of 4´7 % (95 % CI 20´8, 10´5; P 0´10X No effects were found on total cholesterol and HDL-cholesterol, triacylglycerols, apolipoprotein B and A-1, and lipoprotein(a) concentrations. In conclusion, trans alinolenic acid may increase plasma LDL-:HDL-cholesterol and total cholesterol:HDL-cholesterol ratios. Whether diet-induced changes in these ratios truly affects the risk for CHD remains to be established.
Trans-monounsaturated fatty acids from industrially hydrogenated oils increase cholesterol concentrations in the atherogenic serum LDL and decrease those of the antiatherogenic HDL. Therefore, a reduction in the intake of hydrogenated oils has been advocated (Food and Agriculture Organization/World Health Organization, 1993). However, not only trans monounsaturated fatty acids, which represent most of the intake of trans fatty acids, are found in processed fats. Trans isomers of polyunsaturated fatty acids are also formed during oil processing (Ackman et al. 1974) . In particular, a-linolenic acid is easily converted into trans a-linolenic acid.
Soyabean oil and canola oil (low-erucic acid rapeseed oil) are important sources of a-linolenic acid (Hunter, 1990) and trans isomers may represent up to 40 % alinolenic acid (Ackman et al. 1974; Ratnayake et al. 1991; Wolff, 1992 Wolff, , 1993 . There is an increasing recognition that the intake of n-3 fatty acids (such as a-linolenic acid and fish oil fatty acids) should increase. The growing consumption of n-3 fatty acid containing vegetable oils over the last few years (Food and Agriculture Organization, 2000) may therefore result in an increased intake of trans a-linolenic acid from refined oils. Although such trans n-3 polyunsaturated fatty acids are absorbed and incorporated into tissue lipids by man (Chardigny et al. 1993 (Chardigny et al. , 1995 Wolff, 1995) , their health effects have hardly been investigated. Therefore, we have studied the effects of a high-trans a-linolenic acid diet v. a low-trans a-linolenic acid diet on plasma lipid and lipoprotein concentrations in healthy men.
Subjects and methods

Experimental design
The study was designed as a controlled, parallel intervention trial, which was carried out under standardised conditions in three different centres: (1) Universite Â d'Auvergne, Laboratoire de Nutrition Humaine, Clermont-Ferrand, France; (2) Cardiovascular Research Unit, University of Edinburgh, Scotland, UK; (3) Department of Human Biology, Maastricht University, The Netherlands. The study was a part of the TransLinE project (trans aLinolenic acid in Europe) in which the health impact of trans polyunsaturated fatty acids in European populations was examined.
The experiment consisted of two consecutive periods of 6 weeks. During the first period (run-in), all subjects received experimental products made from oil free of trans isomers of oleic, linoleic and a-linolenic acid (1 g trans fatty acids/kg) (trans`free' diet). Thereafter, subjects were randomly allocated to a`high'-or`low'-trans diet. For the next 6 weeks, subjects in the high-trans group received on average 1´4 g trans a-linolenic acid/d (assessed by food diaries), which was provided by an oil containing 45 g trans a-linolenic acid/kg product and a margarine containing 34 g trans a-linolenic acid/kg product. In addition, foods prepared from the oil or margarine were provided (cheese, muffins, pies and biscuits). Identical experimental products free of trans a-linolenic acid were given to the low-trans group. The high-trans a-linolenic acid products had a reduced all cis-a-linolenic acid content, but in all other aspects the high-and low-trans products did not differ (Se Âbe Âdio et al. 2000) . During the preparation of the trans a-linolenic acid-rich oil, formation of trans linoleic acid could not be avoided (He Ânon et al. 1999) . Therefore, for the low-trans group a trans-free rapeseed oil was mixed with an isomerized sunflower oil (50:1, v/v), in order to compensate for the unavoidable formation of 5 g trans isomers of linoleic acid/kg during deodorization of the rapeseed oil for the high-trans group. All products were colour coded so as to blind the subjects.
For the duration of the study, subjects were advised to avoid consuming trans fatty acids: intake of ruminant meat, cheese (except for goats' cheese, which is low in trans), and foods containing hydrogenated fats were avoided. The main part of the trans fatty acid intake was, however, reduced by replacing subjects' usual oil and margarine by experimental products. Before and during week 5 and week 11, subjects recorded their food intake for 4 d, of which at least 1 d was in the weekend, to allow us to estimate their energy and nutrient intakes. Energy and nutrient composition of the diets were calculated separately for the three centres using country-specific food tables and the composition of the experimental fats, oils and products. Unfortunately, no reliable information on the trans fatty acid content of French and Dutch products was available. Therefore, it was not possible to estimate the amount of trans fatty acid in the background diet of subjects from Clermont-Ferrand and Maastricht. Trans 18:1 intake of the Scottish subjects was about 400 mg (Se Âbe Âdio et al. 2000) . Overall, 30 % fat in the habitual diet was replaced by foods prepared with the experimental fats and oils. Subjects visited the dietitian of the department once per week to receive a new supply of products and to measure their body weights.
Subjects recorded in diaries any signs of illness, medication used and any deviations from the protocol. In addition, except for avoidance of consumption of trans fatty acids, subjects were urged not to change their background diets, level of physical exercise, smoking habits, or use of alcohol during the study. The protocol and the aim of the study were fully explained to the subjects, who gave their written informed consent. The study had been approved by the local Medical Ethical Committees.
Subjects
A total of ninety-one men, recruited from a panel of volunteers (Clermont-Ferrand n 32), university staff and students (Edinburgh n 28) and from the general population (Maastricht n 31), entered the study. Volunteers were aged between 18 and 55 years, non-obese, clinically healthy, normotensive and normolipidaemic. During the study, one subject from Clermont-Ferrand dropped out because of a deviation from the protocol interfering with another aspect of this study, and two subjects from Edinburgh because of the constraints of the study. A detailed description of the study design has been reported elsewhere (Se Âbe Âdio et al. 2000) .
Blood sampling and analyses
Free-flowing blood was sampled after an overnight fast at weeks 0, 3, 5, 6, 9, 11 and 12 for lipid and lipoprotein analyses, and at weeks 0, 6 and 12 for measurement of fatty acid composition of plasma cholesteryl esters. Additional measurements will be reported elsewhere. In each centre, all punctures were performed by the same technician, at the same location, and as far as possible at the same time on the same day of the week. All blood samples were taken before 11.00 hours.
Plasma was obtained by centrifugation at 2000 g for 30 min at 48C and stored at 2808C. Plasma total cholesterol and HDL-cholesterol (CHOD-PAP method, Monotest cholesterol; Roche, Mannheim, Germany) and triacylglycerols (GPO-Trinder; Sigma Diagnostics, St Louis, MO, USA) were analysed enzymatically. LDL-cholesterol was calculated with the Friedewald equation (Friedewald et al. 1972) . Plasma apolipoprotein (Apo) A-1 and ApoB were measured using an immunoturbidimetric reaction (UNI-KIT ApoA-1 and UNI-KIT ApoB; Roche, Basel, Switzerland) with antiserum raised in sheep and rabbits respectively. Lipoprotein (Lp)(a) was measured using a kit from Biopool (TintElize; Umea Ê, Sweden). The technicians were blinded to treatment status. All lipid and Lp analyses were centralised in Maastricht in order to eliminate any possible systematic analytical bias between centres. All samples from one subject were analysed within one run, while each run contained samples from each centre.
To monitor dietary compliance, the fatty acid composition of plasma cholesteryl esters was determined by GC by the INRA (Dijon, France) (Se Âbe Âdio et al. 2000)
Statistical analyses
Analysis of covariance was used using the Statistical Package for the Social Sciences (SPSS; SPSS Inc., Chicago, IL, USA) to examine the effect of a high-trans diet v. a low-trans diet (treatment effect) on the week 11+12 means, adjusted for the week 5+6 means, and to check whether results were consistent across the three centres. Because the distributions of triacylglycerols, Lp(a), LDL-:HDL-cholesterol ratio, total cholesterol:HDL-cholesterol ratio and ApoB:ApoA-1 ratio were skewed, a logarithmic transformation was applied to these measurements before analysis. Treatment effects were then expressed as percentage changes and their 95 % CI by taking antilogs. For the sake of uniformity, a similar procedure was used for the other lipid-related variables. All P values are two-tailed, and differences were considered statistically significant when P , 0´05X
Results
For the high-trans group, the daily intake of trans alinolenic acid, as estimated by food records, increased from 66 (range 19±585) mg during the run-in period to 1410 (range 583±2642) mg during the high-trans period (increase of 1344 (range 543±2612) mg). For the lowtrans group, trans a-linolenic acid intake increased from 49 (range 16±310) during the run-in period to 60 (range 2± 404) mg (increase of 10 (range 2236±300) mg P , 0´01 during the low-trans period. As expected, the proportion of trans a-linolenic acid (after adjustment for week 6 values, the mean treatment effect was 0´26 g/100 g fatty acid (95 % CI 0´21, 0´32; P , 0´001 in plasma cholesteryl esters increased significantly on the high-trans diet (from 0´11 (range 0±0´39) to 0´36 (range 0´02±0´74) g/100 g fatty acid) compared with the low-trans diet (from 0´11 (range 0´03±0´28) to 0´10 (range 0±0´21) g/100 g fatty acid) (Fig. 1) . It was surprising that the men consuming a lowtrans diet following the run-in period tended to increase the intake of dietary fat (2´1 (SD 5´7) % energy) whereas the opposite was true for the men in the high-trans group (21´1 (SD 5´4) % energy). The difference in changes nearly reach statistical significance P 0´051X Changes in the intakes of saturated fatty acids and monounsaturated fatty acids also differed (Table 1 ). The changes in protein and carbohydrate intake did not differ between the low-trans (20´5 (SD 2´6) % energy and 21´7 (SD 6´3) % energy respectively) and the high-trans group (0´3 (SD 2´3) % energy and 0´9 (SD 5´6) % energy respectively). Further details of energy and nutrient intakes have been reported elsewhere (Se Âbe Âdio et al. 2000) .
The mean body weight of the subjects was increased by 0´2 (SD 1´1) kg in the high-trans group, which differed significantly from the decrease of 0´4 (SD 1´2) kg in the low-trans group (mean treatment effect of 0´6 (SD 2´4) kg (95 % CI 0´1, 1´1), P 0´03X Changes in plasma lipids and lipoproteins were corrected for body weight changes and changes in the intakes of saturated and monounsaturated fatty acids. The consumption of trans a-linolenic acid did not change plasma total Fig. 1 . Median proportions of trans a-linolenic acid in plasma cholesteryl esters during the run-in period (0±6 weeks) (n 43 in both groups at t 0; n 44 in both groups at t 6) and experimental period of low-(n 44;) or high-trans a-linolenic acid (n 42;) (6±12 weeks). For details of diets and procedures see p. 388. X low trans; W high trans. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids; PUFA, polyunsaturated fatty acids. Mean values were significantly different from those of the low trans fatty acid group: *P , 0´05Y **P , 0´01X ² Run-in (trans-`free' diet) and experimental periods each lasted 6 weeks. For details of diets and procedures see p. 388. ³ Mean change in intake during experimental period.
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Trans a-linolenic acid and plasma lipids cholesterol or triacylglycerol concentrations (Table 2) . LDL-cholesterol concentrations tended to increase in the men consuming the high-trans a-linolenic acid diet, whilst it remained unchanged in the group who consumed the lowtrans diet following the run-in period. However, the treatment effect of 4´7 % failed to reach significance P 0´10X The reverse was observed for plasma HDLcholesterol concentrations, where the concentrations tended to increase slightly in the low-trans group, whilst there was no change in the men consuming the high-trans a-linolenic acid diet. The treatment effect did not reach statistical significance. However, the total cholesterol:HDL-cholesterol and LDL-:HDL-cholesterol ratios increased significantly by 5´1 % P 0´03 and 8´1 % P 0´02 on the high-trans diet compared with the low-trans diet.
Trans a-linolenic acid did not affect plasma ApoB and
ApoA-1 concentrations and their ratio (Table 3) . Lp(a) concentrations tended to fall in men consuming the lowtrans a-linolenic acid diet, whilst concentrations remained constant in the group that was switched to a high-trans alinolenic acid diet. The treatment effect did not reach statistical significance. Treatment effects did not differ significantly between the three centres.
Discussion
In this large multi-centre study with healthy normolipidaemic male volunteers, we did not find any unfavourable effects of high, but not unrealistic intakes of trans isomers from a-linolenic acid on plasma total cholesterol or HDLcholesterol concentrations. LDL-cholesterol concentrations, 
* Subjects received a trans-`free' diet during the 6 week run-in period. For details of diets and procedures see p. 388. ² Treatment effects are expressed as percentage changes. Treatment effects did not differ between the three experimental centres (Clermont-Ferrand, France; Edinburgh, Scotland, UK; Maastricht, The Netherlands). Treatment effects (high v. low trans) were corrected for changes in dietary saturated and monounsaturated fatty acid intake and in body weight.
S. H. F. Vermunt et al.
however, tended to increase, while the LDL-:HDLcholesterol and total cholesterol:HDL-cholesterol ratios were significantly increased on the high-trans diet compared with the low-trans diet. These effects were observed in each centre and were already evident after 3 weeks consumption of the experimental diets (data not shown). Results were corrected for differences in fatty acid intake and body weight between the two groups. We found a difference in the total cholesterol:HDLcholesterol ratio of 0´15 between the low-and the hightrans group. This ratio may predict the risk for CHD even better than total cholesterol or LDL-cholesterol concentrations (Castelli et al. 1986; Kinosian et al. 1994) . It has been suggested that an increase of 1 unit serum cholesterol:HDL-cholesterol ratio may increase the risk of myocardial infarction by 53 % (Stampfer et al. 1991) . This would suggest that the risk for CHD would decrease by 8 % when 1334 mg trans a-linolenic acid is replaced by dietary cis alinolenic acid. It remains to be established, however, if dietinduced changes in HDL-cholesterol:total cholesterol ratio affect CHD risk.
So far, most previous studies have focused on the effects of trans monounsaturated fatty acids on the serum lipoprotein profile (Katan et al. 1995) . Trans monounsaturates have been found to increase LDL-cholesterol and to decrease HDL concentrations relative to its cis isomers (Katan et al. 1995) . As a consequence, trans monounsaturated fatty acid increase the total cholesterol:HDLcholesterol ratio as in our present study. Triacylglycerol concentrations were also increased on diets high in trans monounsaturated fatty acids (Katan et al. 1995) . However, we did not observe effects of trans a-linolenic acid on triacylglycerols. Possibly, intakes of trans isomers were too low, resulting in a limited power of the present study to detect such effects. Alternatively, trans a-linolenic acid may act differently from trans monounsaturates. Lp(a) was also not affected by an intake of 1´4 g trans a-linolenic acid. Studies using trans monounsaturated fatty acids at high intakes, however, showed increased Lp(a) levels (Katan et al. 1995) . One study has reported that partially hydrogenated fish oil, which contains trans isomers of the longer-chain polyunsaturated fatty acids, elevated plasma total cholesterol, LDL-cholesterol, and the LDL-cholesterol:HDL-cholesterol ratio relative to a partially hydrogenated soyabean oil rich in trans monounsaturated fatty acids (Almendingen et al. 1995) . However, results from that study are difficult to interpret because of differences in the composition of other fatty acids between the two hydrogenated oil diets.
Studies with trans-monounsaturates found that effects were similar for women and men (Mensink & Katan, 1990; Mensink et al. 1992; Judd et al. 1994 ) and for subjects with normal and mildly elevated triacylglycerol levels (Nestel et al. 1992a,b) . Whether this is also true for trans polyunsaturated fatty acids should be examined in future studies. Furthermore, it remains to be determined what would be the longer-term effects of a high intake of trans a-linolenic acid.
In our present study subjects consumed an average of 1410 mg trans a-linolenic acid. Based on the fatty acid composition of cholesteryl esters, we considered as a first reasonable estimate that the mean habitual diet in Edinburgh and Maastricht provided approximately 600 mg trans a-linolenic acid/d and in Clermont-Ferrand about 300 mg (Se Âbe Âdio et al. 2000) . Hulshof et al. (1999) , however, have reported that for men the mean daily trans a-linolenic acid plus trans 20:1 intake (these two fatty acids could not be separated by GC) in fourteen Western European countries varied from 20 mg in Italy to 490 mg in Iceland. In addition, Voskuil et al. (1996) have estimated that in 1990 a-linolenic acid intake in the Netherlands was only 1´2 g. Although proportions of a-linolenic acid in serum cholesteryl esters from the Dutch cohort was about 1´7-times higher than in 1990 (0´55 % v. 0´32 %), suggesting that a-linolenic acid has increased considerably during the last years, these studies do not suggest that the average habitual intake of trans a-linolenic acid is as high as we have used. Thus, the amount of trans a-linolenic acid (1´4 g/d) seemed to be high but not unrealistic. Standard deviations and ranges in absolute trans a-linolenic acid intake were rather large. This was not only due to differences in energy intake, but also to inaccuracies inherent to the method used to estimate food intake and to differences in compliance. The oil for this study was deodorised especially for this study, but the composition of the different trans isomers (14 g trans, cis, cis-, 19 g cis, cis, trans-and 3´2 g trans, cis, trans-a -linolenic acid/100 g fatty acids) is typical for commercially available oils (Wolff, 1992; O'Keefe et al. 1994) .
In conclusion, our present study suggests that a high, but not unrealistic intake of trans a-linolenic acid, which is formed during oil processing, may influence the total cholesterol:HDL-cholesterol ratio in an unfavourable way. Increasing the dietary intake of cis, cis, cis-a -linolenic acid has been recommended by an expert panel (De Deckere et al. 1998 ) and obviously it does not make sense to provide a-linolenic acid in the trans form. Careful deodorisation prevents the formation of trans a-linolenic acid (He Ânon et al. 1999) and may help to improve the diet, deliver more cis a -linolenic acid and thereby possibly reduce ischaemic heart disease (De Lorgeril et al. 1994) .
